5 Stocks That Will Probably Make Huge Moves Next Year

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

Tried and true Fools know that we're long-term, buy-to-hold investors. That means temporary market hiccups, or even volatile changes in our stocks' prices, shouldn't bother us too much -- we're focused on a longer time horizon than most.

But it's worth acknowledging that, try as we might, we're all still very human. That means our bodies can betray us, and our hearts can start racing when we look at our portfolios and see that there are huge moves taking place with some of our top holdings.

Knowing that, Motley Fool contributor Brian Stoffel wants to share five stocks that are very likely to make huge moves in 2014. In the following video, Brian explains what companies shareholders should be aware of, and why these stocks are so likely to make big moves.

Speaking of stocks in 2014 ...
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (2) | Recommend This Article (25)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 30, 2013, at 8:31 PM, Foreeverlong wrote:

    Brian,

    I appreciate you highlighting Arena Pharmaceuticals (ARNA) in your report. I agree with you that the Arena is poised for a huge move up in 2014 due to the fact that its marketing partner, Eisai will double it sales reps from 200 to 400 by the first of the year, its direct to consumer TV campaign is likely to start in January 2014, an increasing number of insurance companies will provide coverage for Arena's weight loss drug, Belviq, and marketing for Belviq will expand to a number of other countries. IMO it is not unreasonable to project Arena's PPS going to 2x's to 3x's its current level in 2014, assuming that the market does not have a major correction. However, IMO at its current price it would appear to have little downside.

    I would, however disagree with your point that its efficacy is lower than other competing drugs. The placebo adjusted efficacy of Belviq is 8%+, and VIVUS's Qsymia is about the same. However, IMO Qsymia comes with many complications, whereas Belviq does not.

    Fool On as they say.

  • Report this Comment On December 31, 2013, at 12:13 PM, joven1 wrote:

    Brian,

    I watched my super gain turn much smaller and decided to sell my 600 shares for a small gain purely on the basis of the number of printers sales the company projects. My concern was only one missed sale in any given quarter would send the stock much lower given the short position. Your thoughts are appreciated.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2778270, ~/Articles/ArticleHandler.aspx, 10/25/2014 9:06:24 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement